🔗 Permalink

Inventor profile of:

Kit S. Lam

City:

Davis, California

Country:

United States

Published Applications:

Last publication date:

2026-03-26

Top Assignees for applications by Kit S. Lam

The entities that hold a legal rights for patent applications filed by inventor Lam Kit S.:

The Regents of the University of California 32 Oakland, CA United States
Lawrence Livermore National Security, LLC 4 Livermore, CA United States
PURDUE RESEARCH FOUNDATION 2 West Lafayette, IN United States
The United States of America as represented by the Department of Veteran Affairs (Washington DC) 1 Washington, DC United States
The Regents Of The University Of California Office of Technology, 1 Oakland, CA United States
The Regents of the University of California Office of Technology Transfer, University of California 1 Oakland, CA United States
THE REGENTS OF UNIVERSITY OF CALIFORNIA 1 Oakland, CA United States
The Regents ot the Univershy of California 1 Oakland, CA United States
The Regents of the University of California Office of Technology Transfer 1 Oakland, CA United States

Recent patent applications by Lam Kit S.

Kit S. Lam from Davis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26

US20260083852A1

Human necessities

PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR

#2 | 2026-02-05

US20260035486A1

Chemistry; metallurgy

APOLIPOPROTEIN NANODISCS WITH TELODENDRIMER

#3 | 2023-12-28

US20230416414A1

Chemistry; metallurgy

APOLIPOPROTEIN NANODISCS WITH TELODENDRIMER

#4 | 2023-11-02

US20230346960A1

Human necessities

PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR

#5 | 2022-12-08

US20220387633A1

Human necessities

SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY

#6 | 2022-08-04

US20220241227A1

Human necessities

COMPOSITIONS COMPRISING HDAC INHIBITORS AND RETINOIDS

#7 | 2021-12-30

US20210401993A1

Human necessities

TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS

#8 | 2021-12-23

US20210395302A1

Chemistry; metallurgy

Peptides for activation of cell signaling in osteoprogenitor cells

#9 | 2021-11-11

US20210346518A1

Human necessities

CYANINE-BASED TELODENDRIMERS AND USES FOR TREATING CANCER

#10 | 2021-10-14

US20210317234A1

Chemistry; metallurgy

Apolipoprotein nanodiscs with telodendrimer

#11 | 2021-08-26

US20210261612A1

Chemistry; metallurgy

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

#12 | 2021-04-01

US20210093728A1

Human necessities

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

#13 | 2020-11-26

US20200369723A1

Chemistry; metallurgy

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

#14 | 2019-11-28

US20190358338A1

Human necessities

Hybrid telodendrimers

#15 | 2019-08-22

US20190256503A1

Chemistry; metallurgy

LLS compounds for treatment of cancer

#16 | 2019-04-18

US20190112423A1

Chemistry; metallurgy

Reversibly crosslinked micelle systems

#17 | 2018-03-22

US20180079829A1

Chemistry; metallurgy

Apolipoprotein nanodiscs with telodendrimer

#18 | 2018-02-08

US20180036417A1

Human necessities

PORPHYRIN MODIFIED TELODENDRIMERS

#19 | 2017-10-12

US20170290921A1

Human necessities

Nanocarriers for drug delivery

#20 | 2017-06-22

US20170174722A1

Chemistry; metallurgy

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#21 | 2017-06-22

US20170173174A1

Human necessities

Bladder cancer specific ligand peptides

#22 | 2016-10-27

US20160313341A1

Physics

Functional illumination in living cells

#23 | 2016-08-25

US20160243250A1

Human necessities

TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS

#24 | 2016-01-21

US20160017000A1

Chemistry; metallurgy

RGD-CONTAINING CYCLIC PEPTIDES

#25 | 2015-07-09

US20150190527A1

Human necessities

Bladder cancer specific ligand peptides

#26 | 2015-02-12

US20150045419A1

Chemistry; metallurgy

Reversibly crosslinked micelle systems

#27 | 2014-06-12

US20140161719A1

Human necessities

Porphyrin modified telodendrimers

#28 | 2013-07-04

US20130172270A1

Chemistry; metallurgy

RGD-containing cyclic peptides

#29 | 2013-06-27

US20130165636A1

Chemistry; metallurgy

Apolipoprotein nanodiscs with telodendrimer

#30 | 2013-06-27

US20130164369A1

Human necessities

Telodendrimer nanodiscs without apolipoprotein

#31 | 2012-12-20

US20120322145A1

Chemistry; metallurgy

Three-dimensional cell adhesion matrix

#32 | 2012-09-13

US20120230994A1

Human necessities

Bladder cancer specific ligand peptides

#33 | 2011-12-08

US20110301192A1

Chemistry; metallurgy

Inhibitors of Cyclin Kinase Inhibitor p21

#34 | 2011-11-24

US20110286915A1

Human necessities

Nanocarriers for drug delivery

#35 | 2011-03-24

US20110071301A1

Chemistry; metallurgy

Aβ-binding small molecules

#36 | 2010-12-09

US20100310455A1

Human necessities

Heterocyclic ligands for integrin imaging and therapy

#37 | 2010-01-28

US20100021379A1

Human necessities

Chemical Antibodies for Immunotherapy and Imaging

#38 | 2007-11-06

US10057178

Method for determining differences in molecular interactions and for screening a combinatorial library

#39 | 2007-08-28

US10682659

Method for screening combinational bead library; ligands for cancer cells

#40 | 2006-06-22

US20060134697A1

Chemistry; metallurgy

Method of preparing coded compound libraries

#41 | 2006-02-16

US20060035304A1

Physics

Methods of oligosaccharide profiling for the detection of cancer

#42 | 2006-01-26

US20060019900A1

Chemistry; metallurgy

Alpha-4 beta-1 integrin ligands for imaging and therapy

#43 | 2005-11-17

US20050255042A1

Human necessities

On-demand cleavable linkers for radioconjugates for cancer imaging and therapy

InventorID:

311648 ⎘